Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Matthew Luchini Profile - BMO Capital Analyst
53 Followers
Matthew Luchini BMO Capital
Wall Street Analyst
Success Rate
47 out of 154 transactions made a profit
Average Return
-15.00%
Average return per transaction
Time Frame
Compare to
Copying Matthew Luchini's trades since 2016 and holding each position for 1 Year would result in 30.52% of your transactions generating a profit, with an average return of -15.0% per rating.
Stock Rating Distribution
61.03% Buy
38.97% Hold
0.00% Sell
Distribution of Matthew Luchini's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
US Market
US MarketBest Rating
The most profitable rating made by Matthew Luchini
Matthew Luchini's Stock Coverage
Vitae Pharma
Sep 15, 2016
Hold
Downgraded
―
2Ratings
+111.10%
Regulus
Mar 08, 2018
Hold
Reiterated
$16.44
(1065.96% Upside)
12Ratings
-37.50%
Armo Biosciences Inc
May 10, 2018
Hold
Downgraded
―
2Ratings
-8.30%
Aeglea Biotherapeutics
Jun 14, 2018
Buy
Initiated
$21.00
―
1Ratings
-40.50%
aTyr Pharma
Aug 15, 2018
Hold
Reiterated
$14.00
(507.38% Upside)
12Ratings
―
0.00%
Gamida Cell
Nov 21, 2018
Buy
Initiated
$19.00
(773.56% Upside)
1Ratings
-56.80%
Spark Therapeutics
Feb 25, 2019
Hold
Reiterated
―
14Ratings
-6.09%
Nightstar Therapeutics Limited
Mar 04, 2019
Hold
Downgraded
―
4Ratings
-8.05%
Alder Biopharmaceuticals
Sep 16, 2019
Hold
Downgraded
―
7Ratings
-41.32%
Ra Pharmaceuticals
Oct 10, 2019
Hold
Downgraded
―
6Ratings
+150.56%
List of latest recommendations made by Matthew Luchini. Click to expand and see Matthew Luchini's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Matthew Luchini activity FAQ
What is the performance of Matthew Luchini's recommendations?
The percentage of profitable recommendations made by Matthew Luchini is 31%, and the average return per transaction is -15.00%.
What was Matthew Luchini’s latest rating?
Matthew Luchini latest rating was a hold on GILD with a price target of $72.00, which represents an Downside of -5.35%
What was Matthew Luchini's most profitable rating?
Matthew Luchini’s most profitable ratings was a buy on EVLO stock on Feb 13, 2020 - Feb 13, 2021. The return on the trade was +291.30%.
Where can i see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here